Archynetys Live news trend intelligence
▲ Peaking Business

Most Marijuana Consumers Don't Believe Trump Administration Will Complete Rescheduling This Year, Poll Shows

Consumer skepticism rises as DEA hearings and court challenges test the Trump administration's ability to reschedule cannabis in 2026.

4sources
5articles
3velocity
+0%since first seen
just nowfirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

The federal effort to reschedule marijuana is facing simultaneous pressures from court challenges and official hearings. According to a poll cited by Marijuana Moment, most marijuana consumers do not believe the Trump administration will complete the rescheduling process this year.

Coverage from Reuters, The Hill, and Marijuana Moment emphasizes the start of DEA rescheduling hearings. The Globe and Mail reports that a DEA scientist has testified in court against the agency's own rescheduling posture, while Reuters highlights a specific challenge in the D.C.

Attention now turns to the outcomes of the DEA hearings and the D.C. Circuit challenge to determine if federal rescheduling will proceed.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.

Quick answers

Do consumers expect rescheduling to happen this year?

According to a poll reported by Marijuana Moment, most marijuana consumers do not believe the Trump administration will complete rescheduling this year.

What is happening with the DEA's posture in court?

The Globe and Mail reports that a DEA scientist testified against the DEA's own rescheduling posture.

Where are the legal challenges taking place?

Reuters reports there is a challenge in the D.C. Circuit.

Coverage (5)

Topics

Related trends